SOURCE: GeneThera, Inc.

April 26, 2007 10:32 ET

Congressional Hearing: Is Our Food Safe?

WHEAT RIDGE, CO -- (MARKET WIRE) -- April 26, 2007 -- GeneThera, Inc. (OTCBB: GTHAE) announced that on April 24, 2007 Congress held hearings to examine the role of regulatory bodies in protecting food safety. Recent incidents of contamination have raised questions not only about the U.S. food supply but efforts by the Food and Drug Administration (FDA) and other government agencies to keep our food safe.

In his opening remarks, chairman of the committee Congressman John Dingell of Michigan said, "This is an important hearing on the threat to public health posed by contaminated food products and, frankly, the inadequacies of the FDA." According to Congressman Gene Green of Texas, the FDA's failure is the consequence of "inadequate resources, inadequate standards and inadequate enforcement." "Each outbreak and each food recall has chipped away at the confidence of the American public," he told the subcommittee. "We owe it to consumers and to food manufacturers to restore this confidence."

"I hope these hearings will help alert the American people, Congress and the administration to the seriousness of this issue," said Rep. Bart Stupak, D-Mich., chairman of the House Energy and Commerce subcommittee on oversight and investigations.

In January, the government's fragmented food safety system was added to a congressional "high risk" list, indicating its inefficiencies leave it vulnerable to fraud, waste and abuse. Consumers have to be able to trust the food that is purchased. Without that trust, commerce cannot work. And where failure occurs, oversight is required.

"Safe Harbor" Statement: Certain statements in this release are "forward-looking" statements as defined in the Private Securities Litigation Reform Act of 1995. Such statements are subject to numerous risks and uncertainties. Actual results may vary significantly from the results expressed or implied in such statements. Factors that could cause actual results to materially differ from forward-looking statements include, but are not limited to, the Company's ability to meet the terms and conditions required to obtain its project financing, risks and delays associated with product development, risk of market acceptance of new products, risk of technology or product obsolescence, competitive risks, reliance on development partners and the need for additional capital.